Skip to main content
. 2016 Dec 14;6(1):12–19. doi: 10.1080/21623945.2016.1271511

Figure 2.

Figure 2.

Lysyl oxidase propeptide (LOX-PP) inhibited phosphorylation of ERK1/2 and AKT, two key mediators of FGF-2 receptor signaling. (A) LOX-PP dose dependently inhibited ERK1/2 phosphorylation; (B) LOX-PP dose dependently inhibited AKT phosphorylation; (C) LOX-PP inhibited the prolifreative response of 3T3-L1 cells induced by FGF-2 treatment. (Means ± SEM; *vs. cells without FGF-2 and LOX-PP treatments, P < 0.05; #vs. cells with 5 ng/ml FGF-2 without LOX-PP, P < 0.05).